Your browser doesn't support javascript.
loading
Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia.
Pope, Victor; Hsia, Cyrus C.
Affiliation
  • Pope V; Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Hsia CC; Department of Medicine, Division of Hematology,, London Health Sciences Centre, Room E6-219A, Victoria Hospital, 800 Commissioners Road East, London, Ontario, Canada. cyrus.hsia@lhsc.on.ca.
Ann Hematol ; 103(2): 677-679, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37930364
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Primary Myelofibrosis / Anemia, Hemolytic, Autoimmune Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Canadá
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Primary Myelofibrosis / Anemia, Hemolytic, Autoimmune Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Canadá